TE
Teva Pharmaceutical Industries Limited
TEVJF · OTC
$37.00 +0.00% (+$0.00)
Market Cap $43.1B
P/E Ratio 60.19x
Div. Yield -
ROE 9.19%
Bulios Fair Price
$39.33
6.3% upside
Trenutna cena
$37
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TEVJF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
28 /100
Expensive P/S 2.49x
P/E 60.19x
P/B 5.56x
Growth
68 /100
Growing Book val. growth 0.46%
Rev. growth 7.77%
FCF growth 34.88%
Profitability
58 /100
Moderate Op. margin 15.00%
Gross margin 52.46%
FCF margin 6.09%
Quality
41 /100
Average ROA 1.80%
ROIC 8.98%
Asset turnover 0.43x
Debt
22 /100
High Int. coverage 2.08x
Debt/Equity 2.18x
Net debt/EBITDA 4.03x
Stability
57 /100
Moderate EPS volatility 195.30%
Beta 0.93x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TEVJF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard D. Francis
Employees
33,346
Headquarters
Tel Aviv
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report